Tag: Sexual Health

From Candle to Dilator: Treating Vaginismus in Turkey

Aysel brought out her candles wrapped in stretch wrap and put them on the coffee table in the middle of our interview. She was very proud of showing her progress to me through these home-made candle dildos. When she brought them out to the living room, I was still sipping my tea and my half-eaten piece of cake she baked for me was now sitting next to her candles on the coffee table. She made these dildos herself with the help of her sister-in-law, her elti,  in her kitchen by shaping them, melting them thinner, and combining them together for different sizes so she could use them as apparatuses to treat her vaginismus, the inability to engage in penile-vaginal intercourse. (read more...)

A Technology of Empowerment and Governance: The IUD/IUS and Sexual Health Care in Toronto, Canada

The intrauterine device (IUD) and the intrauterine system (IUS) have a long and complicated history. The IUD is a contraceptive device inserted into the uterus, which serves as a physical barrier to prevent sperm from fertilizing the egg. Its earliest form can be linked to the work of Ernst Gräfenberg, who in 1929 created the ring IUD (Thiery 1997). Over the course of several decades, the IUD was constructed and re-constructed in terms of the materials used, its physical shape, and its promotion to women. Through the development process, some devices, such as the Dalkon Shield, caused irreparable damage. In 1969, the first copper IUD was created by Jaime Zipper and Howard J. Tatum, which took the now easily recognizable T-shape form. While the copper IUD was considered successful in terms of its ability to prevent pregnancy, women commonly had it removed due to increased bleeding during menstruation. Subsequently, the intrauterine system (IUS) was created, first by Antonio Scommegna in the 1960s using progesterone and later by Tapani Luukkainen in 1976 using levonorgestrel; this shift increased its effectiveness from a duration of one year to five years. After over a decade of testing, the Mirena IUS was released in Finland – it would not be approved for sale in the United States until 2001. (read more...)

PrEP in Thailand in the time of COVID-19

In 2012, the first PrEP (pre-exposure prophylaxis) drugs came onto the market, poised to revolutionize the field of HIV prevention. ‘The Pill’ promised to usher in a kind of sexual revolution, particularly for gay men and trans women. Sexual rights activists and health workers around the world analogized PrEP to birth control, suggesting that PrEP would allow particular sexual minority populations to secure bodily autonomy and serve as a tool for the self-management and mitigation of risk. (read more...)